Liver health may change how lung cancer drug works
NCT ID NCT05329623
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study looked at how different levels of liver function affect the way the body processes the drug JDQ443. Researchers gave a single dose to 33 people with small cell lung cancer who had mild, moderate, or severe liver problems, and compared them to healthy volunteers. The goal was to understand safety and drug levels to guide future dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
Texas Liver Institute
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.